2 Drug Stocks Popping on Fresh "Buy" Ratings

ABEO was oversold heading into today's trading

Oct 12, 2018 at 9:59 AM
facebook X logo linkedin


Mizuho Securities initiated coverage on Abeona Therapeutics Inc (NASDAQ:ABEO) with a "buy" rating and $17 price target, representing expected upside of 69.3% to last night's close at $10.04. In reaction, ABEO stock is up 6.6% to trade at $10.70.

Analysts are already upbeat toward the rare disease specialist, with all seven in coverage maintaining a "strong buy" rating. Short sellers, on the other hand, have actively targeted ABEO this year, with short interest up more than 34% from the Jan. 1 reporting period.

This steady selling pressure has likely had some effect on the equity's technical trajectory, with the shares down 33% year-to-date. Plus, ABEO stock hit a new annual low of $9.66 this past Tuesday, and its 14-day Relative Strength Index (RSI) settled last night at 26 -- in oversold territory. In other words, today's bounce may have been in the cards.

Bernstein started Sarepta Therapeutics Inc (NASDAQ:SRPT) with an "outperform" rating and $170 price target -- a 39.3% premium to Thursday's close at $122.01 -- with the brokerage firm waxing optimistic on the company's Duchenne muscular dystrophy (DMD) treatment. Against this backdrop, SRPT stock is up 5.3% to trade at $128.50.

Today's positive price action has the equity on track to snap its six-session losing streak. This sell-off stalled yesterday near the security's 120-day moving average -- a trendline that cushioned mid-February pullback as well. Year-to-date, Sarepta Therapeutics stock has added 131%.

Short-term options traders, meanwhile, have been more put-heavy than usual, per SRPT's top-heavy Schaeffer's put/call open interest ratio (SOIR) of 1.12 -- in the 98th annual percentile. This is due to heavy accumulations of open interest at the November 95 and 105 puts, the stock's top two open interest positions.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI